business
Canaccord raises Hims and Hers stock price target on weight loss drugs
Canaccord raises Hims and Hers stock price target on weight loss drugs
Read full story on Investing.com → More top storiesAlso covered by
Yahoo Finance
Norwegian Cruise Line Holdings (NCLH) Is The Best Travel Stock To Buy As Citi Raises Price Target
Yahoo Finance
Morgan Stanley Raises its Price Target on U.S. Bancorp (USB)
Yahoo Finance
Morgan Stanley Raises Price Target on PNC Financial (PNC)
Fast Company
GLP-1 weight loss drugs are now $50 a month for some Americans. Here’s who qualifies
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop